Enzo Biochem, Inc. (ENZ)
NYSE: ENZ · Real-Time Price · USD
1.130
0.00 (0.00%)
Nov 4, 2024, 4:00 PM EST - Market closed

Enzo Biochem Revenue

In the fiscal year ending July 31, 2024, Enzo Biochem had annual revenue of $31.91M with 2.72% growth.

Revenue (ttm)
$31.91M
Revenue Growth
+2.72%
P/S Ratio
1.80
Revenue / Employee
$167,932
Employees
190
Market Cap
59.04M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jul 31, 202431.91M846.00K2.72%
Jul 31, 202331.06M-1.58M-4.85%
Jul 31, 202232.64M-85.09M-72.27%
Jul 31, 2021117.73M41.71M54.87%
Jul 31, 202076.02M-5.15M-6.34%
Jul 31, 2019 Pro Pro Pro
Jul 31, 2018 Pro Pro Pro
Jul 31, 2017 Pro Pro Pro
Jul 31, 2016 Pro Pro Pro
Jul 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
P3 Health Partners 1.40B
Cryo-Cell International 31.84M
Kronos Bio 8.41M
Aligos Therapeutics 7.97M
Shattuck Labs 4.12M
Syros Pharmaceuticals 387.00K
Revenue Rankings